Výsledky vyhledávání

Ultraschall-Flußmessung bei Stenosen und Verschlüssen der Arteria carotis interna

Autor: Müller Hr, Radü Ew

Publikováno v: Ultraschall in der Medizin. 6:74-82

Blood flow in the common carotid artery as measured by means of the QFM system of Furuhata in 100 patients with angiographically proven obstructive or occlusive lesions of the internal carotid or middle cerebral artery, was compared with the normal b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c3b95cda8d32deb6dc184e65b5a4528f
https://doi.org/10.1055/s-2007-1006030

Zobrazit plný text záznamu

Periodical

Alertness dysfunction in MS: structural lesions and functional consequences

Autor: Calabrese, P, De Vera, A, Haupts, M, Kappos, L, Schlegel, U, Radü, EW, Opwis, K, Penner, IK

Publikováno v: Aktuelle Neurologie; 20240101, Issue: Preprints

Zobrazit plný text záznamu

Periodical

Syrinx like formations as a rare feature of spinal cord involvement in multiple sclerosis

Autor: Weier, K, Nägelin, Y, Thöni, A, Hirsch, J, Radü, EW, Kappos, L, Gass, A

Publikováno v: Aktuelle Neurologie; 20240101, Issue: Preprints

Zobrazit plný text záznamu

Periodical

Folgen des Absetzens von Natalizumab auf die Krankheitsaktivität und das Immunsystem bei der Multiplen Sklerose

Autor: Stuve, O, Cravens, P, Frohman, E, Phillips, J, Marra, C, Miller, D, Radü, EW, von Geldern, G, Cepok, S, Monson, N, Cohen Tervaert, J, De Baets, M, Kim, R, Racke, M, Hemmer, B

Publikováno v: Aktuelle Neurologie; 20240101, Issue: Preprints

Zobrazit plný text záznamu

MRI in the diagnosis and follow-up of multiple sclerosis. Guidelines for quality assurance

Autor: Gass A, Kappos L, Radü EW, FILIPPI , MASSIMO

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10495::79afacefebe7001dd3cd63cbc8409562

Zobrazit plný text záznamu

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

Autor: Strasser Fuchs, S, Berger, T, Vass, K, Sindic, C, Dubois, B, Dive, D, Debruyne, J, Metz, L, Rice, G, Duquette, P, Lapierre, Y, Freedman, M, Traboulsee, A, O'Connor, P, Stourac, P, Taláb, R, Zapletalová, O, Kovárová, I, Medová, E, Fiedler, J, Frederiksen, J, Brochet, B, Moreau, T, Vermersch, P, Pelletier, J, Edan, G, Clanet, M, Clavelou, P, Lebrun Frenay, C, Gout, O, Kallela, M, Pirttilä, T, Ruutiainen, J, Koivisto, K, Reunanen, M, Elovaara, I, Villringer, A, Altenkirch, H, Wessel, K, Hartung, Hp, Steinke, W, Kölmel, H, Oschmann, P, Diem, R, Dressel, A, Hoff, F, Baum, K, Jung, S, Felicitas Petereit, H, Reske, D, Sailer, M, Köhler, J, Sommer, N, Hohlfeld, R, Henn, Kh, Steinbrecher, A, Tumani, H, Gold, R, Rieckmann, P, Komoly, R, Gács, G, Jakab, G, Csiba, L, Vécsei, L, Miller, A, Karussis, D, Chapman, J, Ghezzi, A, Comi, G, Gallo, Paolo, Cosi, V, Durelli, L, Anten, B, Visser, L, Myhr, Km, Szczudlik, A, Selmaj, K, Stelmasiak, Z, Podemski, R, Maciejek, Z, Cunha, L, Sega Jazbec, S, Montalbán, X, Arbizu, T, Saiz, A, Bárcena, J, Arroyo, R, Fernández, O, Izquierdo, G, Casanova, B, Lycke, J, Kappos, L, Mattle, H, Beer, K, Coleman, R, Chataway, J, O'Riordan, J, Howell, S, Miller, Dh, Polman, Ch, Bauer, L, Ghazi, M, Pohl, C, Sandbrink, R, Barkhof, F, Uitdehaag, B, de Vera, A, Wu, S, Radü, Ew, Mcfarland, Hf, Kesselring, J, Petkau, Aj, Toyka, K. V.

Publikováno v: Lancet Neurology, 8(11), 987-997. Lancet Publishing Group
Kappos, L, Freedman, M S, Polman, C H, Edan, G, Hartung, H P, Miller, D, Montalban, X, Barkhof, F, Radu, E W, Metzig, C, Bauer, L, Lanius, V, Sandbrink, R & Pohl, C 2009, ' Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial ', Lancet Neurology, vol. 8, no. 11, pp. 987-997 . https://doi.org/10.1016/S1474-4422(09)70237-6
The Lancet Neurology, Vol. 8, no.11, p. 987-97 (2009)

BACKGROUND: The Betaferon/Betaseron in newly emerging multiple sclerosis for initial treatment (BENEFIT) trial investigated the effect of treatment with interferon beta-1b after a clinically isolated syndrome. The 5-year active treatment extension co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32de5c13d4271bf7c0708befa9bfb69e
https://lirias.kuleuven.be/handle/123456789/257768

Zobrazit plný text záznamu

Effect of early versus delayed interferon beta-1b treatment on desability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

Autor: Kappos, L, Freedman, Ms, Polman, Ch, Edan, G, Hartung, Hp, Miller, Dh, Montalbán, X, Barkhof, F, Radü, Ew, Bauer, L, Dahms, S, Lanius, V, Pohl, C, Strasser Fuchs, Sandbrink R. investigators—Austria: S., Graz, T. Berger, Innsbruck, Vass, K., Sindic, V. i. e. n. n. a. Belgium: C., Brussels, B. Dubois, Leuven, D. Dive, Liège, Debruyne, J., Metz, G. h. e. n. t. Canada: L., Calgary, G. Rice, London, Duquette, P., Lapierre, Y., Montreal, M. Freedman, Ottawa, A. Traboulsee, Vancouver, O’Connor, P., Štourač, T. o. r. o. n. t. o. Czech Republic: P., Brno, R. Taláb, Hradec Kralove, O. Zapletalová, Ostrava, Kovářová, I., Medová, E., Prague, Fiedler, J., Frederiksen, P. l. z. e. n. Denmark: J., Brochet, G. l. o. s. t. r. u. p. France: B., Bordeaux, T. Moreau, Dijon, P. Vermersch, Lille, J. Pelletier, Marseille, G. Edan, Rennes, M. Clanet, Toulouse, P. Clavelou, Clermont Ferrand, C. Lebrun Frenay, Nice, Gout, O., Kallela, P. a. r. i. s. Finland: M., Helsinki, T. Pirttilä, Kuopio, J. Ruutiainen, Turku, K. Koivisto, Seinäjoki, M. Reunanen, Oulu, Elovaara, I., Villringer, T. a. m. p. e. r. e. Germany: A., Altenkirch, H., Berlin, K. Wessel, Braunschweig, Hartung, H. P., Steinke, W., Düsseldorf, H. Kölmel, Erfurt, P. Oschmann, Giessen, R. Diem, Göttingen, A. Dressel, Greifswald, F. Hoffmann, Halle/saale, K. Baum, Hennigsdorf, S. Jung, Homburg/saar, Petereit, H., Reske, D., Cologne, M. Sailer, Magdeburg, J. Köhler, Mainz, N. Sommer, Marburg, R. Hohlfeld, Munich, K. H. Henn, Offenbach, A. Steinbrecher, Regensburg, H. Tumani, Ulm, Gold, R., Rieckmann, P., Würzburg, Komoly, R., Gács, G., Jakab, G., Budapest, L. Csiba, Debrecen, Vécsei, L., Miller, S. z. e. g. e. d. Israel: A., Haifa, D. Karussis, Jerusalem, Chapman, J., Ghezzi, Tel H. a. s. h. o. m. e. r. Italy: A., Gallarate, G. Comi, Milan, Gallo, Paolo, V. Cosi, Pavia, Durelli, L., Anten, T. u. r. i. n. Netherlands: B., Sittard, Visser, L., Myhr, T. i. l. b. u. r. g. Norway: K. M., Szczudlik, B. e. r. g. e. n. Poland: A., Kraków, K. Selmaj, Łódź, Z. Stelmasiak, Lublin, R. Podemski, Wrocław, Maciejek, Z., Cunha, B. y. d. g. o. s. z. c. z. Portugal: L., Sega Jazbec, C. o. i. m. b. r. a. Slovenia: S., Montalbán, L. j. u. b. l. j. a. n. a. Spain: X., Arbizu, T., Saiz, A., Barcelona, J. Bárcena, Barakaldo, R. Arroyo, Madrid, O. Fernández, Málaga, G. Izquierdo, Seville, Casanova, B., Lycke, V. a. l. e. n. c. i. a. Sweden: J., Kappos, M. ö. l. n. d. a. l. Switzerland: L., Basel, H. Mattle, Bern, Beer, K., Coleman, St G. a. l. l. e. n. UK: R., Aberdeen, J. Chataway, London, J. O’Riordan, Dundee, S. Howell, Sheffield

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3657::d69f002d037d3074ebfdce741e09369a
http://hdl.handle.net/11577/1773904

Zobrazit plný text záznamu

Aspirin as a risk factor for hemorrhage in patients with head injuries

Autor: Radü Ew, Marc A. Reymond, Gratzl O, Marbet G

Publikováno v: Neurosurgical review. 15(1)

The role of aspirin as a risk factor in the occurrence of intracranial bleeding following head injury was investigated. Chronic subdural hematoma appears to be a suitable model for the evaluation of risk factors in the development of hemorrhage. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f2ed8325a25ad0492f96f1265be77ef
https://pubmed.ncbi.nlm.nih.gov/1584433

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání